https://www.selleckchem.com/products/bi-2865.html
ssociated with increased LDLR but not PCSK9 expression. Surprisingly, E2 therapy attenuates atherogenesis and cholesterol levels post-OVX without altering LDLR but increases PCSK9 expression and promoter activity. This is the first documentation of increased PCSK9 expression with E2 therapy and raises questions about balancing physiological estrogenic / PCSK9 homeostasis and targeting PCSK9 in women - are there effects beyond cholesterol?Dietary obesity compromises brain function, but the effects of high-fat food on synaptic transmissio
Like
Comment
Share
